Company Description
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics.
Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products.
Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon’s gloves, procedure kits, and orthopedic implants.
Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products.
It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands.
It provides logistics and supply chain optimization services to domestic and international consumers.
It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning.
The company was founded in 1966 and is based in Northfield, Illinois.
| Country | United States |
| Founded | 1966 |
| IPO Date | Dec 17, 2025 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 45,000 |
| CEO | James Boyle |
Contact Details
Address: 3 Lakes Drive Northfield, Illinois 60093 United States | |
| Phone | 847 949 5500 |
| Website | medline.com |
Stock Details
| Ticker Symbol | MDLN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $29.00 |
| CIK Code | 2046386 |
| CUSIP Number | 58507V107 |
| ISIN Number | US58507V1070 |
| Employer ID | 33-1845288 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| James M. Boyle | Chief Executive Officer and Director |
| Michael B. Drazin | Chief Financial Officer |
| Stephen L. Miller | Chief Operating Officer |
| Douglas P. Golwas | Chief Commercial Officer |
| Jessi L. Corcoran | Chief Accounting Officer |
| Marshall Lancaster | Chief Information Officer |
| Karen M. King | Global Head Investor Relations |
| Alex M. Liberman | Chief Legal Officer |
| Ben Fox | Vice President of Corporate Communications |
| Jenny Lee | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 6, 2026 | 424B4 | Prospectus |
| Mar 4, 2026 | EFFECT | Notice of Effectiveness |
| Mar 3, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 25, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 25, 2026 | 10-K | Annual Report |
| Feb 25, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13G | Filing |
| Feb 13, 2026 | SCHEDULE 13G | Filing |
| Feb 13, 2026 | SCHEDULE 13G | Filing |
| Feb 13, 2026 | SCHEDULE 13G | Filing |